Article
Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma.
JCO precision oncology - 1 Jan 2026
Gamboa Adriana C, Lewis Kever A, Prakash Laura R, Li Zhouxuan, Qiao Wei, Zhao Dan, Hurd Mark W, Yousef Mahmoud, Ikoma Naruhiko, Kim Michael P, Lee Jeffrey E, Maxwell Jessica E, Tzeng Ching-Wei D, Katz Matthew H G, Snyder Rebecca A
Abstract excerpt
PURPOSE: The incidence of young-onset pancreatic cancer (YO-PC) has risen over the past two decades, yet its molecular characteristics and long-term outcomes remain poorly defined. METHODS: We retrospectively evaluated patients with PC treated at a tertiary referral center from 2016 to 2022 who had available molecular data. Patients were classified as YO-PC (≤50 years) or average-onset PC (AO-PC, >50 years). A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
